Lupin Ltd - 500257 - Approval Of The Audited Financial Statements For The Quarter And Year Ended March 31, 2025 And Recommend Final Dividend Of Rs. 12/- Per Equity Share I.E. 600 % Of The Face Value Of Rs. 2/ Each Fully Paid Up For The Financial Year Ended March 31, 2025

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

1997.0000 13.20 (0.67%)

NSE Nov 04, 2025 15:31 PM

Volume: 1.2M

Lupin Ltd.

14 May 2025

1997.00

0.67%

Result

Lupin Ltd - 500257 - Approval Of The Audited Financial Statements For The Quarter And Year …

BSE India

Approval of the Audited Financial Statements for the quarter and year ended March 31, 2025 and recommend the Final Dividend of Rs. 12/- per Equity Share i.e. 600 % of the Face Value of Rs. 2/- each fully paid up for the financial year ended March 31, 2025.

pdf